Press Releases

Mar 27, 2026

Derek Hwang

Press Releases

LB Pharmaceuticals Presents New Analysis from the Phase 2 NOVA-1 Trial Highlighting LB-102’s Potential Impact on Cognitive Performance at the 2026 Annual Congress of the Schizophrenia International Research Society (SIRS)

LB Pharmaceuticals announced new positive data from the Phase 2 NOVA-1 trial showing that LB-102, a novel benzamide antipsychotic candidate, directly improves cognitive performance in patients with acute schizophrenia. These findings, presented at the 2026 Schizophrenia International Research Society Congress, support ongoing Phase 3 and additional…

LBRX

Mar 27, 2026

Nina Shah

Press Releases

Allot Files Annual Report on Form 20-F for the Year Ended December 31, 2025

Allot Ltd., a global provider of Security-as-a-Service and network intelligence solutions, announced the filing of its annual report on Form 20-F for the year ended December 31, 2025. The report includes audited financial statements and is available on the SEC and company websites. The company serves over 500 service providers and 1000 enterprises …

ALLT

Mar 27, 2026

Caleb Monroe

Press Releases

Celldex Presents Positive Data from Phase 2 Chronic Spontaneous Urticaria and Phase 2 Cold Urticaria and Symptomatic Dermographism Studies Demonstrating Rapid, Profound and Durable Improvements in Patient Quality of Life at AAD 2026

Celldex Therapeutics presented positive Phase 2 clinical trial results for barzolvolimab in chronic spontaneous urticaria (CSU), cold urticaria (ColdU), and symptomatic dermographism (SD) at the 2026 AAD Annual Meeting. The data demonstrated rapid, profound, and durable improvements in patient quality of life across multiple domains, with sustained…

CLDX

Mar 27, 2026

Priya Menon

Press Releases

Results Presented at 2026 American Academy of Dermatology (AAD) Annual Meeting Provide Additional Support for the Therapeutic Potential of ATI-2138

Aclaris Therapeutics presented additional positive Phase 2a clinical trial results for ATI-2138, an investigational oral inhibitor targeting ITK and JAK3, showing significant improvements in atopic dermatitis severity, itch, and quality of life. The therapy demonstrated strong efficacy and tolerability, supporting its potential in treating immuno-i…

ACRS

Mar 27, 2026

Derek Hwang

Press Releases

Maris-Tech Receives Order to Conduct Situational Awareness Pilot on Armored Vehicle in the United States

Maris-Tech Ltd., a Nasdaq-listed company specializing in AI-based edge computing video solutions for defense, announced it received an order to conduct a situational awareness pilot on an armored vehicle in the U.S. The pilot integrates Maris-Tech's Diamond Ultra platform with night-vision and thermal imaging sensors to enhance battlefield awarenes…

MTEK

Mar 27, 2026

Derek Hwang

Press Releases

Silynxcom Receives a $1.1 Million Purchase Order for Tactical Systems from a Middle East Military Force

Silynxcom Ltd. announced receiving a purchase order exceeding $1.1 million from a long-standing Middle East military customer for its ruggedized tactical communication headset devices. This order underscores the trust in Silynxcom's innovative, combat-proven tactical systems that deliver advanced communication and protective solutions in demanding …

SYNX

Mar 27, 2026

Avery Klein

Press Releases

Anaptys Board of Directors Approves Spin-Off of First Tracks Biotherapeutics

AnaptysBio's Board has approved the spin-off of First Tracks Biotherapeutics, a clinical-stage biotech focused on autoimmune disease therapeutics. The new entity will trade on Nasdaq under ticker TRAX starting April 20, 2026. First Tracks Bio will commence operations with $180 million in cash and a robust leadership team, enabling a focused approac…

ANAB

Mar 27, 2026

Derek Hwang

Press Releases

Kartoon Studios to Release Shareholder Letter and Business Update Including AI Animated Video Featuring Company Executives and Iconic Characters

Kartoon Studios (NYSE American: TOON) will release its annual Shareholder Letter and a groundbreaking AI-animated video business update featuring company executives alongside iconic characters from its upcoming Hundred Acre Wood series. The presentation aims to demonstrate the company's innovative AI-driven animation production capabilities, which …

TOON

Mar 27, 2026

Derek Hwang

Press Releases

United-Guardian Reports 2025 Financial Results

United-Guardian, Inc. reported a 13% decline in net sales for fiscal year 2025 to $10.5 million and a net income drop to $2.1 million, impacted primarily by reduced cosmetic ingredient sales due to distributor inventory excess and weakened demand in China amid tariffs and local competition. Positives include growth in pharmaceutical and medical lub…

UG

Mar 27, 2026

Caleb Monroe

Press Releases

SB Financial Group, Inc. Announces Schedule for First Quarter 2026 Results

SB Financial Group, Inc., a diversified financial services holding company, announced it will release its first quarter 2026 financial results on April 23, 2026, after market close. The company will hold a conference call and webcast for investors on April 24, 2026, to discuss the results. SB Financial operates community banking, mortgage banking, …

SBFG

Mar 27, 2026

Caleb Monroe

Press Releases

Jeffs' Brands: KeepZone AI Enters into Agent Agreement with Skyline Software Systems to Offer 3D Geospatial Visualization Solutions to Global Security Markets

Jeffs' Brands Ltd, listed on Nasdaq, announced that its subsidiary KeepZone AI entered a non-exclusive agreement to market and distribute Skyline Software Systems' 3D GIS and photogrammetry platforms in designated territories across the Middle East, Europe, and Latin America. This partnership expands KeepZone's AI-driven security technology portfol…

JFBR

Mar 27, 2026

Hana Yamamoto

Press Releases

Trailblazer Merger Corporation I Announces Completion of Business Combination with Cyabra Strategy, Ltd.

Trailblazer Merger Corp. I (TBMC) announced the completion of its previously announced business combination with Cyabra Strategy, Ltd. As a result, TBMC has canceled the special meeting of stockholders that had been scheduled for March 27, 2026.

TBMC

Mar 27, 2026

Derek Hwang

Press Releases

Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement

Callan JMB Inc. announced its role as an independent infrastructure and oversight partner in a collaboration to support U.S.-based manufacturing scale-up of Biostax Corp's multi-indication immune restoration platform, JKB-122 (Lodonal™). The collaboration advances the platform toward Phase 2b/3 clinical development, ensuring compliance and readines…

CJMB

Mar 27, 2026

Caleb Monroe

Press Releases

Maryland Fire Departments Awarded $520,000 for Cancer Screenings using 20/20 BioLabs’ OneTest ™ Multi-Cancer Early Detection Blood Test

20/20 BioLabs, Inc. has received over $520,000 in funding from the Maryland Department of Health to provide its patented OneTest™ multi-cancer early detection blood test to more than 1,400 firefighters across 18 Maryland fire departments. This represents a significant increase in screenings compared to the prior year and reflects growing public sec…

AIDX

Mar 27, 2026

Leila Farooq

Press Releases

Hudson Technologies Signs Licensing Agreement with Solstice Advanced Materials for the Reclamation and Resale of Patented HFO Refrigerants

Hudson Technologies has signed a licensing agreement with Solstice Advanced Materials to reclaim and resell patented HFO refrigerants R-448A and R-449A in the U.S. and Canada. This move enhances Hudson's presence in the commercial refrigeration market amidst regulatory phase-downs of higher GWP refrigerants, aligning with efforts to provide sustain…

HDSN

Mar 27, 2026

Avery Klein

Press Releases

Jyong Biotech Updates the Potential Clinical Benefits and Advantages of Its Plant-Derived Innovative Drug MCS®-2

Jyong Biotech Ltd., listed on Nasdaq as MENS, announced updates on its plant-derived drug candidate MCS®-2, emphasizing its clinical advantages in treating benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS). The drug has completed multiple Phase III trials in the US and Taiwan with strong safety and efficacy profiles, and ho…

MENS

Mar 27, 2026

Leila Farooq

Press Releases

One and One Green Technologies. INC Launches Luzon Copper-Gold Ore Tailings Slag Venture to Address Projected 150,000-Ton Global Copper Supply Deficit

One and One Green Technologies. INC (NASDAQ: YDDL), a licensed hazardous waste recycler in the Philippines, announced a new business venture to recover copper-gold ore tailings slag in Luzon. This strategic initiative targets the projected global copper supply deficit of 150,000 metric tons in 2026 by partnering with local small-scale miners and le…

YDDL

Mar 27, 2026

Ajmal Hussain

Press Releases

ORIC® Pharmaceuticals to Report Combination Dose Optimization Data From Phase 1b Trial of Rinzimetostat in Patients with mCRPC

ORIC Pharmaceuticals announced plans to report combination dose optimization data from its Phase 1b trial of rinzimetostat in metastatic castration resistant prostate cancer patients. The presentation will occur during a webcast and conference call on March 31, 2026. This update provides insights into dosing strategies for an investigational allost…

ORIC

Mar 27, 2026

Derek Hwang

Press Releases

BranchOut Food Inc. Announces Fourth Quarter and Full Year 2025 Earnings Call and Shareholder Update

BranchOut Food Inc., a food technology company specializing in natural fruit and vegetable snacks using its proprietary GentleDry process, announced a conference call to discuss its Q4 and full-year 2025 financial results along with a corporate and shareholder update scheduled for March 31, 2026. The company highlighted its patented dehydration tec…

BOF

Mar 27, 2026

Derek Hwang

Press Releases

Ocean Power Technologies Secures Order for Fully Integrated WAM-V for an Underwater Research Customer in the Nordics

Ocean Power Technologies announced securing a contract to deliver a fully integrated WAM-V autonomous surface vehicle to a new underwater research customer in the Nordics. This order marks an expansion of the company's presence in the Nordic region and demonstrates ongoing demand across multiple sectors including defense, surface inspections, and u…

OPTT

Mar 27, 2026

Ajmal Hussain

Press Releases

Cyabra Announces Completion of Business Combination with Trailblazer Merger Corp.

Cyabra, a company dedicated to identifying coordinated manipulation in online narratives and protecting digital trust, has completed its business combination with Trailblazer Merger Corp. Cyabra's common stock is set to begin trading on Nasdaq on March 27, 2026, under the ticker CYAB. The combination supports Cyabra's mission to combat disinformati…

CYAB

Mar 27, 2026

Maya Rios

Press Releases

Quantum Biopharma’s 2025 Audited Year End Financial Results Maintain ‘No Going Concern’ Status

Quantum BioPharma Ltd. announced its audited financial results for 2025 showing a strong balance sheet with $11.3 million in cash and digital assets, improved working capital, and reduced operating expenses. The company completed Phase 1 toxicology studies for its oral MS drug candidate Lucid-MS, advancing toward Phase 2 trials. Additionally, clini…

QNTM

Mar 27, 2026

Avery Klein

Press Releases

Inflection Point Acquisition Corp. VI Announces Pricing of $220 Million Initial Public Offering

Inflection Point Acquisition Corp. VI, a special purpose acquisition company (SPAC), announced the pricing of its IPO, offering 22 million units at $10 each, expected to raise $220 million. The units will trade on Nasdaq under ticker IPFXU, with separate trading expected for shares and warrants under IPFX and IPFXW respectively. The company aims to…

IPFXU

Mar 27, 2026

Derek Hwang

Press Releases

Hydrofarm Holdings Group Announces Fourth Quarter and Full Year 2025 Results

Hydrofarm Holdings Group, Inc. announced its fourth quarter and full year 2025 financial results showing a 32.7% reduction in net sales for Q4 compared to the prior year, driven by industry oversupply and price decreases. Despite improvements in gross profit margins and reduced operating expenses due to restructuring efforts, the company reported a…

HYFM

Mar 27, 2026

Nina Shah

Press Releases

Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones

Glucotrack, Inc. announced significant progress towards filing an Investigational Device Exemption (IDE) with the U.S. FDA in Q2 2026 to initiate a U.S. clinical trial for its implantable continuous blood glucose monitoring system. Following successful first-in-human trials in Brazil and a follow-up study in Australia, the company completed key tri…

GCTK